| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC23499 | BD-1047 Featured | BD-1047 is a potent, selecitve Sigma 1 receptor (σ1) antagonist with Ki of 0.93 nM. |
|
| DC10280 | BD1063 dhydrochloride Featured | BD1063 dhydrochloride is a potent and selective sigma 1 receptor antagonist. |
|
| DC9709 | BDA-366 Featured | BDA-366 is a Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy. |
|
| DC21101 | BDCRB Featured | BDCRB (GW 275175) is a potent and selective inhibitor of human CMV replication by blocking the processing and maturation of viral DNA.. |
|
| DC10860 | BDP5290 Featured | BDP5290 is a potent inhibitor of both ROCK and MRCK with IC50s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1, ROCK2, MRCKα and MRCKβ, respectively. |
|
| DC20763 | BDP8900 | BDP8900 (BDP-8900) is a highly potent and selective Myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor with IC50 of 43 nM (MRCKβ), >100-fold selectivity over related ROCK1 or ROCK2. |
|
| DC20764 | BDP9066 | BDP9066 (BDP-9066) is a highly potent and selective Myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor with IC50 of 43 nM, >100-fold selectivity over related ROCK1 or ROCK2. |
|
| DC12596 | BDP-NAC | BDP-NAC is a novel persulfide donor that shows selectivity towards H2 O2 over other potential oxidative or nucleophilic triggers, resulting in the sustained release of the persulfide of N-acetyl cysteine (NAC). |
|
| DC20765 | BDT001 Featured | BDT001 is a first-in-class, non-competitive FLT3 negative allosteric modulator, effectively prevents extracellular cytokine FL binding to FLT3 with IC50 of 11 uM. |
|
| DC20319 | Beauvericin | Beauvericin is a cyclic hexadepsipeptide with antibiotic and insecticidal effects, shows activity against Gram-positive bacteria and mycobacteria, and is also capable of inducing programmed cell death in mammals.. |
|
| DC9718 | BEBT-908（CUDC-908） Featured | BEBT-908（CUDC-908）is a novel PI3K/HDAC inhibitor. |
|
| DC9964 | BEC hydrochloride Featured | BEC is a boronic acid-based arginine analog that acts as a slow-binding, competitive transition state inhibitor of arginase I and II (Ki = 310 nM for human recombinant type II arginase, pH 7.5). |
|
| DC20668 | Becampanel | Becampanel (AMP 397) potent, competitive antagonist of the AMPA receptor (AMPAR) with IC50 of 11 nM. |
|
| DC9172 | Beclomethasone Dipropionate | Beclometasone dipropionate is a potent glucocorticoid agonist; it is a prodrug of the free form, beclometasone. |
|
| DC8809 | Bedaquiline fumarate Featured | Bedaquiline fumarate(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis. |
|
| DC21007 | Befiradol Featured | Befiradol (F13640, NLX 112) is a highly potent, selective 5-HT1A receptor agonist with Ki of 2.7 nM. |
|
| DC12290 | Befiradol hydrochloride (F 13640 hydrochloride) | Befiradol hydrochloride is a selective 5-HT1A receptor agonist. |
|
| DC20030 | Begacestat (GSI-953) | Begacestat (GSI-953) is a selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase (IC50Aβ40=15 nM) for the treatment of Alzheimer's disease. |
|
| DC7082 | Belinostat (PXD101) Featured | Belinostat (PXD101) is a novel pan-HDAC inhibitor with IC50 of 27 nM, with activity demonstrated in cisplatin-resistant tumors. |
|
| DC10448 | Belizatinib(TSR-011) Featured | Belizatinib(TSR-011) is an orally available inhibitor of both the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the tropomyosin-related kinases (TRK) TRKA, TRKB, and TRKC, with potential antineoplastic activity. |
|
| DC8160 | ZGN-440(Beloranib) | Beloranib is being studied as a first-in-class obesity therapy that demonstrates a unique mechanism of action through methionine aminopeptidase 2 (MetAP2 ) inhibition. |
|
| DC11470 | Belotecan hydrochloride(CKD-602) Featured | Belotecan hydrochloride (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic and water-soluble camptothecin derivative. |
|
| DC12278 | Belvarafenib Featured | Belvarafenib is a potent and pan RAF (Rapidly Accelerated Fibrosarcoma) inhibitor, with IC50s of 56 nM, 7 nM and 5 nM for B-RAF, B-RAFv600E and C-RAF respectively. |
|
| DC20135 | Bemesetron (MDL 72222) | Bemesetron (MDL 72222) is a selective 5-HT3 receptor antagonist with an IC50 of 0.33 nM. Neuroprotective effect. |
|
| DC9152 | Benazepril Hydrochloride | Benazepril hydrochloride, an angiotensin converting enzyme inhibitor, which is a medication used to treat high blood pressure. |
|
| DC6908 | Bendamustine HCL (SDX-105, Cytostasane) Featured | Bendamustine HCL (Ribomustin, Treanda, SDX-105) is a DNA-damaging agent with IC50 of 50 μM. |
|
| DC12299 | Benfluralin | Benfluralin is a kind of herbicide and an agrochemical which can be used as a pre-emergence herbicide used for the control of grass and other weeds in a range of food and non-food crops. |
|
| DCAPI1606 | Benserazide | Benserazide is a peripherally-acting aromatic L-amino acid decarboxylase (AAAD) or DOPA decarboxylase inhibitor. |
|
| DC10701 | Benzamide (NSC 404988) Featured | Benzamide (NSC 404988) is a bioactive compound. |
|
| DC20185 | Benzamidine HCl | Benzamidine is an inhibitor of serine proteases with Ki values of 35, 350, and 220 µM for trypsin, plasmin, and thrombin, respectively. |
|
